LNSR earnings date and last-quarter result: last quarter beat, P/E 5.87. Updated 2026-07-23.
LENSAR (LNSR) Research Hub
LENSAR (LNSR) trades on NASDAQ, US in the Healthcare (Medical - Equipment & Services) sector. As of 2026-10-26, shares last closed at 5.96 USD (-1.81%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 5.87, market cap 0.07B. This hub links to the full technical, earnings and options research available for LNSR.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Equipment & Services) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 5.96 USD (-1.81%) |
| 52-week range | 4.95 USD – 9.25 USD |
| Trend regime | Range |
| 14-day RSI | 28.5 (Oversold) |
| Trailing P/E | 5.87 |
| Market cap | 0.07B |
| Dividend yield | 0.00% |
Available research for LNSR
Covered Call on LNSR: how it works, illustrative setup around the real 5.96 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on LNSR: how it works, illustrative setup around the real 5.96 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on LNSR: how it works, illustrative setup around the real 5.96 USD price, max profit/loss, breakeven and when to use it. Educational.
LNSR technical analysis: range, last 5.96 USD, RSI 28.5, 52w range 4.95 USD–9.25 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is LNSR in?
LENSAR (LNSR) is classified under Healthcare (Medical - Equipment & Services), listed on NASDAQ, US.
Is LNSR in an uptrend or downtrend?
As of 2026-10-26, LNSR is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is LNSR's trailing P/E ratio?
LNSR's trailing P/E is 5.87, with a market cap of 0.07B. See the earnings research page for full valuation detail.